Front Endocrinol (2019) 10:509
GLP-1 drugs improve health and reduce long-term costs, yet society still hesitates to embrace them
Even though the absolute risk to a nursing baby remains unknown, regulatory bodies and prescribing physicians typically advise discontinuing either breastfeeding or delaying semaglutide until weaning is complete
Under the new program, Medicare enrollees will be eligible to receive one of three drugs Foundayo (the new once-a-day tablet), Wegovy, or Zepbound for weight loss specifically
Only very mild chemical peels, such as lactic acid peels, may be considered safe in selected cases
Furthermore, some users in our sample discontinue GLP-1 medications, allowing us to assess whether changes in food demand persist after stopping